Designed for the CHRO/CPO/Head of HR at the Heart of Emerging Biopharma OrganizationsMark your calendars for November because LEAP HR: Emerging Biopharma is back! Returning to Boston from November 19-20, we are uniting the most senior leaders from emerging biopharma organizations across the US for 2 days of unmissable content and networking. There has never been a more crucial time for leaders to unite as they navigate HR efficiency with more limited resources and funding than ever before and look ahead to prepare for an optimistic future of investment and growth. This is your best opportunity to deep dive into the pressing issues challenging senior leaders on a day to day basis: rethinking organizational efficiencies, adapting to new agile way working, how to truly engage and retain business critical biopharma talent and more. Unveil 30+ case studies of how HR leaders are building the high-impact strategies to better engage and develop employees, stay close to business needs and retain critical talent in order to tackle upcoming adversity and expertly navigate today's volatile biotech market. URLs:Tickets: https://go.evvnt.com/2547364-2?pid=5569Brochure: https://go.evvnt.com/2547364-3?pid=5569 Date and Time: Tuesday, 19 November 2024 at 09:00 to Wednesday, 20 November 2024 at 15:10 Venue details: The Colonnade, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States Category: Conferences | Health Prices:Life Science Organization Pricing (Conference Only): USD 2299.00,Life Science Organization Pricing - 2 Day Pass (Conference + 1 Pre-Conference Breakfast Deep-Dive): USD 2648.00,Life Science Organization Pricing - 2 Day Pass (Conference + 2 Pre-Conference Breakfast Deep-Dives): USD 2997.00,Solution Provider Pricing (Conference Only): USD 3699.00 Speakers: Adam Thomas, Chief People and Experience Officer, MOMA Therapeutics, Alicja Januszewicz, SVP People and Culture, Marengo Therapeutics, Alyssa Ozimek-Maier, Head of Human Resources, Photys Therapeutics, Anna Goranson, Chief People Officer, Terray Therapeutics, Bryan Tierney, Associate Director Talent Acquisition, Syndax Pharmaceuticals, Caren Block, Chief People Officer, Clasp Therapeutics, Crystal Zuckerman, Vice President Human Resources, PMV Pharmaceuticals Inc., Dee Olomajeye, Dragon Vice President, People and Culture Strategy, Senti Biosciences, Derrick Richardson, SVP People and Culture, Alumis, Dierdre Vitale, Vice President Talent and Experience, Syndax Pharmaceuticals, Emily Cox VP, Head of People, Apogee Therapeutics, Erin Schellhammer, Chief People Officer, Cogent Biosciences, Georgette Verdin, Chief People Officer, Bitterroot Bio, Ileen Winick, Chief People Officer, Candel Therapeutics, Jennifer Leonard, Chief People Officer and Senior Vice President Information Technology, EyePoint Pharmaceuticals, Jennifer Patterson, Senior Director, Head of Human Resources, Longboard Pharmaceuticals, Jill Murray, Vice President Human Resources, SalioGen Therapeutics, Jill Wilson Director, Human Resource Business Partner, Verve Therapeutics, John Gilleeny, Vice President People and Culture, SOPHiA GENETICS, Kaitlin Duffy, Executive Director Human Resources, Verve Therapeutics, Kelly Schick, Chief People Officer, C4 Therapeutics, Kevin Chin, Chief Medical Officer, Marengo Therapeutics, Kosta Kleitsas, Head of People, Dyno Therapeutics, Madeline Serrano, Director People Experience and Operations, Monte Rosa Therapeutics, Mary Weger, Chief People Officer, ProKidney, Niamh Alix, Chief Human Resources Officer, Prime Medicine, Pauline Dufresne, Vice President, Head of People, X4 Pharmaceuticals